<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01134471</url>
  </required_header>
  <id_info>
    <org_study_id>Ostene-project</org_study_id>
    <nct_id>NCT01134471</nct_id>
  </id_info>
  <brief_title>Improvement of Hemostasis Techniques After Median Sternotomy</brief_title>
  <official_title>Improvement of Hemostasis Techniques After Median Sternotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ceremed, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare 2 different hemostatic agents (Bonewax and Ostene)to
      a control group with regards to bleeding, bone healing, pain and infection in a patient group
      all undergoing median sternotomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone healing in sternum</measure>
    <time_frame>6 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire regarding physical and emotional well being</measure>
    <time_frame>6 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain-score (VAS)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood product consumption</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mediastinitis</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>superficial infection</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding through the chest tube</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Sternal Dehiscence</condition>
  <condition>Sternal Infection</condition>
  <condition>Sternal Pain</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bonewax</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with the hemostatic bonewax</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ostene</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with the hemostatic Ostene</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ostene</intervention_name>
    <description>applied to sternal surface</description>
    <arm_group_label>Ostene</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bonewax</intervention_name>
    <description>applied to sternal surface</description>
    <arm_group_label>Bonewax</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men undergoing elective cardiac surgery at the Cardiac surgery department of Aarhus
             University Hospital, Skejby

          -  no clopidogrel-treatment

          -  no osteoporoses

          -  less than 2 co-morbidities in the form of obesity (BMI&gt;30), COPD, chronic steroid use,
             renal failure, immunosuppression and diabetes

        Exclusion Criteria:

          -  profuse sternal bleeding

          -  serious complications to the surgery fx cerebral infarction

          -  re-operation due to bleeding
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rikke Vestergaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Cardiothoracic surgery, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital, Skejby, Dept. of Cardiothoracic surgery</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2010</study_first_submitted>
  <study_first_submitted_qc>June 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2010</study_first_posted>
  <last_update_submitted>June 1, 2010</last_update_submitted>
  <last_update_submitted_qc>June 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Rikke Vestergaard/ MD</name_title>
    <organization>Aarhus University Hospital, Skejby, Cardiothorasic surgery dept.</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

